GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » Institutional Ownership

Healius (ASX:HLS) Institutional Ownership : 37.55% (As of May. 01, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Healius Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Healius's institutional ownership is 37.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Healius's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Healius's Float Percentage Of Total Shares Outstanding is 0.00%.


Healius Institutional Ownership Historical Data

The historical data trend for Healius's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Institutional Ownership Chart

Healius Historical Data

The historical data trend for Healius can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 38.90 39.06 39.59 39.01 38.78 45.24 39.61 37.83 36.85 37.55

Healius Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Healius (ASX:HLS) Business Description

Traded in Other Exchanges
N/A
Address
161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius (ASX:HLS) Headlines

No Headlines